Transcarent Raises $200M in Series C Funding

Transcarent, a Palo Alto, Calif.-based health and care experience company, raised $200m in Series C funding.

The round, which brings total funding raised to date to $298m, was led by Kinnevik and Human Capital, with participation from Ally Bridge Group and health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center, as well as existing investors, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.

The company intends to use the funds to expand operations and its business reach.

Led by Glen Tullman, Chief Executive Officer, Transcarent is a health and care experience company for employees of self-insured employers and their families. It provides personalized health and care support for virtually all of the most common and most challenging needs, including not just essentials like urgent care but also including lower cost medications, personalized behavioral health symptom evaluation and support, along with, where appropriate, specialty care like surgeries, care at home, cancer, and expert second opinions. Members get 24/7 access to digital and live guidance (real humans) and direct access to care.